Homing of the myeloma cell clone

Acta Oncologica

Volumn 39, Issue 7, 2000, Pages 771-776

  Vanderkerken, K ^a   Van Camp, B ^a   De Greef, C ^a   Vande Broek, I ^a   Asosingh, K ^a   Van Riet, I ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN; CHEMOTACTIC FACTOR; LAMININ; LAMININ 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; BASEMENT MEMBRANE; BONE MARROW; CELL CLONE; CELL MIGRATION; CELL STRAIN; CELLULAR DISTRIBUTION; CONFERENCE PAPER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELL MOVEMENT; CLONE CELLS; DOWN-REGULATION; MICE; MICE, INBRED C57BL; MULTIPLE MYELOMA; NEOPLASM CIRCULATING CELLS; STROMAL CELLS;

EID: 0033674454     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750063488     Document Type: Conference Paper

References (30)

1. Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies
2. Evidence for peripheral blood B lymphocytes but not T lymphocyte involvement in multiple myeloma
3. Evidence that multiple myeloma immunoglobulin heavy chain VDJ genes contain somatic mutations but show no intraclonal variation
4. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state
5. Circulating plasma cells in multiple myeloma: Characterization and correlation with disease stage
6. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen
7. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma
8. Homing behaviour of the malignant cell clone in multiple myeloma
9. Idiopatic paraproteinemia II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice
10. Animal model of human disease
11. Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KaLwRij mouse
12. Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse
13. Follow-up of bone lesions in an experimental multiple myeloma mouse model: Description of an in vivo technique using radiography dedicated for mammography
14. Lymphocyte homing and homeostasis
15. Adhesion and homing of blood-borne cells in bone marrow microvessels
16. Selective transendothelial migration of hematopoietic progenitor cells: A role in homing of progenitor cells
17. Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines
18. Functional insulin and insulin-like growth factors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines
19. Multiple myeloma cells are protected by dexamethasone-induced apoptosis by insulin-like growth factors
20. The regulation of IGF-I receptor gene expression
21. Insulin and IGF-I increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226
22. Insulin-like growth factor-1 acts as a chemoattracrant for multiple myeloma cells
23. New concepts in insulin-like growth factor receptor physiology
24. Extensive extramedullary disease in myeloma
25. Extramedullary plasmacytomas and solitary plasma cell tumours of bone
26. Inactivation of tumor suppressor genes, p53 and RB1, in plasma cell dyscrasias
27. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias
28. The oncoprotein phenotype of plasma cells from patients with multiple myeloma
29. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer
30. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer